All In Biotech

Drug Trial Radar · NCT07361289

A Study to Assess the Real-World Effectiveness of Mavacamten in Adult Patients With Obstructive Hypertrophic Cardiomyopathy in China

A Single-Arm Observational Study to Assess the Real-World Effectiveness of Mavacamten in Adult Patients With Obstructive Hypertrophic Cardiomyopathy in China

Last checked: Nov 20, 2026Latest source record: Nov 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

500

Planned (sponsor's estimate)

Start

Jan 15, 2026

Primary completion

Aug 22, 2028

Study completion Aug 28, 2028

Sponsor

Lead sponsor
Bristol-Myers SquibbBristol Myers Squibb (BMY)
Sponsor type
Industry
First posted
Jan 23, 2026

More drug trials from this sponsor

Design

Study type
Observational
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to assess the effectiveness of mavacamten treatment in Chinese adults with symptomatic obstructive hypertrophic cardiomyopathy (HCM) in real-world clinical practice

Conditions

  • Hypertrophic Cardiomyopathy

Interventions

  • MavacamtenDrug

    According to the product label

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from baseline in Valsalva left ventricular outflow tract (LVOT) gradientTime frame: Week 48, Week 96
  2. Change from baseline in resting valsalva left ventricular outflow tract (LVOT) gradientTime frame: Week 48, Week 96

Locations

15 sites in 1 country. Site status is shown where the registry gives one.

  • Local Institution - 0003

    Harbin, China · Not yet recruiting

  • Local Institution - 0010

    Jinan, China · Not yet recruiting

  • Zhongshan Hospital Fudan University

    Shanghai, China · Recruiting

  • Local Institution - 0008

    Beijing, Beijing Municipality, China · Not yet recruiting

  • Peking Union Medical College Hospital

    Beijing, Beijing Municipality, China · Recruiting

  • Peking University First Affiliated Hospital

    Beijing, Beijing Municipality, China · Recruiting

  • The First Affiliated Hospital, Sun Yat-sen University

    Guangzhou, Guangdong, China · Recruiting

  • The Second Afilliated Hospital of Hebei Medical University

    Jiazhuang, Hebei, China · Recruiting

  • Local Institution - 0007

    Zhengzhou, Henan, China · Not yet recruiting

  • Suzhou Municipal Hospital

    Suzhou, Jiangsu, China · Recruiting

  • The Second Hospital of Jilin University

    Changchun, Jilin, China · Recruiting

  • The First Affiliated Hospital of Dalian Medical University

    Dalian, Liaoning, China · Recruiting

  • Local Institution - 0013

    Xi'an, Shan3xi, China · Withdrawn

  • West China Hospital of Sichuan University

    Chengdu, Sichuan, China · Recruiting

  • The Second Affiliated Hospital of Zhejiang University School of Medicine

    Hangzhou, Zhejiang, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.